HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Induction of remission in patients with non-Hodgkin lymphomas with high degree of malignancy - preliminary comparison of 2 chemotherapy programs: CHOP-B (cyclophosphamide, adriamycin, vincristine, encorton, bleomycin) and MEV-A (methotrexate, cyclophosphamide, vincristine and adriamycin)].

AuthorsJ A Walewski
JournalNowotwory (Nowotwory) 1983 Jul-Sep Vol. 33 Issue 3 Pg. 259-65 ISSN: 0029-540X [Print] Poland
Vernacular TitleIndukcja remisji u chorych na chłoniaki nieziàrnicze o wysokiej złośliwości - wstepne porównanie dwóch programów chemioterapii: CHOP-B (cyklofosfamid, adriamycyna, winkrystyna, enkorton, bleomycyna) i MEV-A (metotreksat, cyklofosfamid, winkrystyna, adriamycyna).
PMID6198637 (Publication Type: Clinical Trial, Comparative Study, English Abstract, Journal Article)
Chemical References
  • Bleomycin
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone
  • Methotrexate
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Bleomycin (administration & dosage)
  • Clinical Trials as Topic
  • Cyclophosphamide (administration & dosage)
  • Doxorubicin (administration & dosage)
  • Drug Administration Schedule
  • Humans
  • Lymphoma (drug therapy)
  • Methotrexate (administration & dosage)
  • Neoplasm Invasiveness
  • Neoplasm Regression, Spontaneous
  • Prednisone (administration & dosage)
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: